Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
NEWS
Pfizer and BioNTech Report Strong Immune Response from LP.8.1...
Pfizer and BioNTech have announced topline Phase 3 clinical trial data showing a robust immune...
Nutrien to Divest 50% Equity Stake in Profertil S.A. for US$600...
Nutrien Ltd. has announced an agreement to sell its 50 percent equity stake in Argentina-based...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...

